DZ2556A1 - Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant. - Google Patents
Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant.Info
- Publication number
- DZ2556A1 DZ2556A1 DZ980166A DZ980166A DZ2556A1 DZ 2556 A1 DZ2556 A1 DZ 2556A1 DZ 980166 A DZ980166 A DZ 980166A DZ 980166 A DZ980166 A DZ 980166A DZ 2556 A1 DZ2556 A1 DZ 2556A1
- Authority
- DZ
- Algeria
- Prior art keywords
- blocker
- beta
- serotonin reuptake
- reuptake inhibitor
- novel compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2556A1 true DZ2556A1 (fr) | 2003-02-15 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ980166A DZ2556A1 (fr) | 1997-07-11 | 1998-07-08 | Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (id) |
| JP (1) | JP2002508003A (id) |
| KR (1) | KR20010021644A (id) |
| CN (1) | CN1262627A (id) |
| AP (1) | AP2000001728A0 (id) |
| AR (1) | AR016128A1 (id) |
| AU (1) | AU9340198A (id) |
| BG (1) | BG104119A (id) |
| BR (1) | BR9810996A (id) |
| CA (1) | CA2295822A1 (id) |
| CO (1) | CO4950552A1 (id) |
| DZ (1) | DZ2556A1 (id) |
| EA (1) | EA200000112A1 (id) |
| GB (1) | GB9714675D0 (id) |
| HU (1) | HUP0003074A3 (id) |
| ID (1) | ID24191A (id) |
| IL (1) | IL133869A0 (id) |
| MA (1) | MA24604A1 (id) |
| NO (1) | NO20000107D0 (id) |
| OA (1) | OA11276A (id) |
| PE (1) | PE99699A1 (id) |
| PL (1) | PL338017A1 (id) |
| SK (1) | SK72000A3 (id) |
| TR (1) | TR200000074T2 (id) |
| WO (1) | WO1999002142A2 (id) |
| ZA (1) | ZA986138B (id) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1121111E (pt) | 1998-10-15 | 2010-05-17 | Imp Innovations Ltd | Compostos para o tratamento de perda de peso |
| JP4613275B2 (ja) | 1998-11-02 | 2011-01-12 | エラン ファーマ インターナショナル，リミティド | 多粒子改質放出組成物 |
| KR20130010512A (ko) | 1999-10-29 | 2013-01-28 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| KR100960200B1 (ko) | 2000-10-30 | 2010-05-27 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| WO2006030306A2 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
| DE69607904T2 (de) * | 1995-08-16 | 2000-10-05 | Eli Lilly And Co., Indianapolis | Potenzierung von Serotonin-Wirkstoffresponz |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107D0/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA24604A1 (fr) | 1999-04-01 |
| AR016128A1 (es) | 2001-06-20 |
| PL338017A1 (en) | 2000-09-25 |
| CN1262627A (zh) | 2000-08-09 |
| NO20000107L (no) | 2000-01-10 |
| TR200000074T2 (tr) | 2000-05-22 |
| JP2002508003A (ja) | 2002-03-12 |
| BG104119A (en) | 2000-12-29 |
| PE99699A1 (es) | 1999-12-21 |
| IL133869A0 (en) | 2001-04-30 |
| CO4950552A1 (es) | 2000-09-01 |
| OA11276A (en) | 2003-07-31 |
| BR9810996A (pt) | 2000-08-08 |
| EP0996466A2 (en) | 2000-05-03 |
| NO20000107D0 (no) | 2000-01-10 |
| AU9340198A (en) | 1999-02-08 |
| AP2000001728A0 (en) | 2000-03-31 |
| WO1999002142A3 (en) | 1999-04-15 |
| WO1999002142A2 (en) | 1999-01-21 |
| CA2295822A1 (en) | 1999-01-21 |
| KR20010021644A (ko) | 2001-03-15 |
| ZA986138B (en) | 2000-01-10 |
| GB9714675D0 (en) | 1997-09-17 |
| EA200000112A1 (ru) | 2000-10-30 |
| HUP0003074A3 (en) | 2001-12-28 |
| SK72000A3 (en) | 2000-12-11 |
| ID24191A (id) | 2000-07-13 |
| HUP0003074A2 (hu) | 2001-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| CY2007024I2 (el) | Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων | |
| CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
| ID20053A (id) | Hipolipidemat 1,4-benzotiazepin-1,1-dioksida | |
| EE9600186A (et) | Neurokiniini (tahhüülkiniini) antagonistid | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| EE9700245A (et) | 5-HT tagasihaarde inhibiitori kombinatsioon selektiivse 5-HT1A antagonistiga | |
| DK1437359T3 (da) | Hidtil ukendte 3,6-hemiketaler fra 9a-azalidklassen | |
| DE69417023D1 (de) | Grubenstempel | |
| IT1302243B1 (it) | Sintesi dell'1,1,1,3,3-pentafluoropropano. | |
| DZ2576A1 (fr) | Compositions parentérales d'alatrofloxacine. | |
| DZ2556A1 (fr) | Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant. | |
| FI973229A0 (fi) | Uusi farmaseuttinen koostumus | |
| DE69523869D1 (de) | Zeicheninformationsprozessor | |
| DZ1965A1 (fr) | Composition pharmaceutique nouvelle. | |
| FR2753400B1 (fr) | Caractere d' estampage articule | |
| FI960909A0 (fi) | Bentsotiofeeniyhdisteet, välituotteet, koostumukset ja menetelmät | |
| FR2714674B1 (fr) | Agents hydrotropes et compositions les contenant. | |
| BR7300677U (pt) | Jogo fórmula-1 | |
| BR7300676U (pt) | Jogo fórmula-1/S | |
| ID21318A (id) | Turunan-turunan 2,4-diaminopirimidin | |
| DZ2203A1 (fr) | Traceur d'ellipses. | |
| ES1038037Y (es) | "juego didactico". | |
| ITTO940131V0 (it) | Nuovo modello di spartito musicale. | |
| UA1693S (uk) | Набір етикеток "суми" |